Psoriasis and Psoriatic Arthritis: A Strategic Analysis of the Market in the United States

This report focuses on the applications of current and advanced therapeutics to the treatment of psoriasis and psoriatic arthritis, the options they present, and the progress that is being made in these fields. The major market effects of new therapeutics, with the potential of a breakthrough drug always a possibility, are expected to be seen over the next ten years. The technology trends selected in conjunction with the growing interest in psoriasis and its treatment present the most informative picture of advances in psoriasis and psoriatic arthritis therapeutics and the markets that result.

The report’s market analysis includes:

• extensive discussion of the pathology of the multiple forms of the disease
• thorough examination of the epidemiology in the United States segmented by severity and projected to 2016
• comprehensive analysis of the total available market and serviceable available market for psoriasis (by severity) and psoriatic arthritis through 2016
• monthly cost per patient forecasts for psoriasis (by severity) and psoriatic arthritis through 2016

In depth company profiles of major competitors and a meticulous review of the expert conclusions and strategic implications for competitors serious about winning in the psoriasis therapeutics field round out this systematic analysis.

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including immunologists, dermatologists, rheumatologists, pathologists, research scientists, business development managers and marketing managers.